Filter Results:
(509)
Show Results For
- All HBS Web (705)
- Faculty Publications (223)
Show Results For
- All HBS Web (705)
- Faculty Publications (223)
Sort by
- 04 Dec 2018
- First Look
New Research and Ideas, December 4, 2018
of risk operating in both geographies. Macroeconomic and policy turbulence emerged as the biggest source of risk for Latin Americans, while excessive bureaucracy was the biggest source of risk for South Asians. Political instability,... View Details
Keywords: Dina Gerdeman
- August 2017
- Article
Tort Reform and Innovation
By: Alberto Galasso and Hong Luo
Current academic and policy debates focus on the impact of tort reforms on physicians’ behavior and medical costs. This paper examines whether these reforms also affect incentives to develop new technologies. We develop a theoretical model that predicts that the impact... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Care and Treatment; Technological Innovation; Legal Liability; Medical Devices and Supplies Industry
Galasso, Alberto, and Hong Luo. "Tort Reform and Innovation." Journal of Law & Economics 60, no. 3 (August 2017): 385–412.
- February 2010 (Revised March 2012)
- Case
U.S. Healthcare Reform: International Perspectives
By: Arthur A. Daemmrich and Elia Cameron
The national economic implications of rising healthcare costs were poorly understood, even as the United States, Germany, and the United Kingdom instituted reforms in early 2010. Presenting opportunities for cross-national policy learning, this case describes the... View Details
Keywords: Macroeconomics; Insurance; Governing Rules, Regulations, and Reforms; Health Care and Treatment; Laws and Statutes; Business and Government Relations; Health Industry; Public Administration Industry; Germany; United Kingdom; United States
Daemmrich, Arthur A., and Elia Cameron. "U.S. Healthcare Reform: International Perspectives." Harvard Business School Case 710-040, February 2010. (Revised March 2012.)
- 24 Jun 2008
- First Look
First Look: June 24, 2008
research outputs in a panel dataset spanning the careers of 3,862 academic life scientists. Using inverse probability of treatment weights (IPTW) to account for the dynamics of self-selection into patenting, we find that patenting has a... View Details
Keywords: Martha Lagace
- 12 Oct 2011
- First Look
First Look: October 12
form of corporate social responsibility (CSR) through a sustainable business model that also generates superior financial performance. Read the paper: http://www.europeanbusinessreview.com/?p=4538 An Exploration of Optimal Stabilization View Details
Keywords: Sean Silverthorne
- 22 Apr 2014
- First Look
First Look: April 22
accounts across treatment groups. Migrants offered the greatest degree of control over savings accumulated the most savings at the partner bank, compared to others who were offered less or no control over savings. Effects of this View Details
Keywords: Sean Silverthorne
- 20 Jan 2009
- Research & Ideas
Risky Business with Structured Finance
of the junior and mezzanine tranches falling quickly toward zero and the value of the senior tranche declining substantially as default probabilities rise. Earlier in their paper, however, the researchers illustrate the difficulty of estimating the default rate and... View Details
- 23 Nov 2009
- Research & Ideas
Management’s Role in Reforming Health Care
opinion, there is another important set of discussions to be had around how we actually organize care. Many of these issues are managerial in nature, rather than policy issues. Questions we need to answer include: What is the best way of... View Details
- 04 Oct 2010
- Research & Ideas
Introverts: The Best Leaders for Proactive Employees
productive groups would win iPods.) Each group consisted of one assigned leader and three followers, plus two research assistants—"confederates"—who pretended to be followers. Some of the confederates were told to approach their... View Details
Keywords: by Carmen Nobel
- 25 Jan 2021
- Book
In a Nutshell, Why American Capitalism Succeeded
History Initiative and a lecturer at Harvard Business School. Sean Silverthorne: Tell me a little about the book. Walter Friedman: My assignment was to write a narrative history, stretching roughly from the arrival of European merchants... View Details
- Research Summary
Overview
Having grown up in a developing country, Professor Sikochi’s research focus is driven by a desire to understand how capital flows to firms and entrepreneurs with the ultimate goal to help build capital markets in the developing economies. To this end, he conducts... View Details
- 31 Mar 2023
- Research & Ideas
Can a ‘Basic Bundle’ of Health Insurance Cure Coverage Gaps and Spur Innovation?
Professor of Public Policy at Harvard’s John F. Kennedy School of Government, conducted the research with Katherine Baicker of the University of Chicago and Mark Shepard, associate professor of public policy... View Details
- 2023
- Article
Evidence from the First Shared Medical Appointments (SMAs) Randomised Controlled Trial in India: SMAs Increase the Satisfaction, Knowledge, and Medication Compliance of Patients with Glaucoma
By: Nazlı Sönmez, Kavitha Srinivasan, Rengaraj Venkatesh, Ryan W. Buell and Kamalini Ramdas
In Shared Medical Appointments (SMAs), patients with similar conditions meet the physician together and each receives one-on-one attention. SMAs can improve outcomes and physician productivity. Yet privacy concerns have stymied adoption. In physician-deprived nations,... View Details
Sönmez, Nazlı, Kavitha Srinivasan, Rengaraj Venkatesh, Ryan W. Buell, and Kamalini Ramdas. "Evidence from the First Shared Medical Appointments (SMAs) Randomised Controlled Trial in India: SMAs Increase the Satisfaction, Knowledge, and Medication Compliance of Patients with Glaucoma." e0001648. PLoS Global Public Health 3, no. 7 (2023).
- September 2012 (Revised August 2015)
- Case
Shanghai Pharmaceuticals
By: Regina E. Herzlinger and Natalie Kindred
Shanghai Pharmaceuticals (SPH), a vertically integrated Chinese pharmaceutical conglomerate, was considering its strategic options in the context of a rapidly evolving industry, policy, and economic environment. The company—essentially a collection of subsidiaries... View Details
Keywords: Business Subsidiaries; Business Conglomerates; Vertical Integration; Decision Choices and Conditions; Mergers and Acquisitions; Consolidation; Health Care and Treatment; Global Strategy; State Ownership; Pharmaceutical Industry; Health Industry; Shanghai; United States; Europe
Herzlinger, Regina E., and Natalie Kindred. "Shanghai Pharmaceuticals." Harvard Business School Case 313-016, September 2012. (Revised August 2015.)
- 08 Mar 2021
- In Practice
COVID Killed the Traditional Workplace. What Should Companies Do Now?
A year ago, COVID-19 forced many companies to send employees home—often with a laptop and a prayer. Now, with COVID cases subsiding and vaccinations rising, the prospect of returning to old office routines appears more possible. But will employees want to flock back to... View Details
Keywords: by Dina Gerdeman
- 18 Apr 2016
- Research & Ideas
The Cost of Leaning In
However, the Forced treatment revealed a different story. Forcing men to negotiate every time was neither harmful nor helpful, the researchers found. But when women workers were forced to always negotiate, there were more instances where... View Details
Keywords: by Carmen Nobel
- August 2015
- Article
Hospital Board and Management Practices Are Strongly Related to Hospital Performance on Clinical Quality Metrics
By: Thomas C Tsai, Ashish K. Jha, Atul A. Gawande, Robert S. Huckman, Nicholas Bloom and Raffaella Sadun
National policies to improve health care quality have largely focused on clinical provider outcomes and, more recently, payment reform. Yet the association between hospital leadership and quality, although crucial to driving quality improvement, has not been explored... View Details
Keywords: Hospitals; Quality; Governing and Advisory Boards; Management Practices and Processes; Service Delivery; Health Care and Treatment; Health Industry
Tsai, Thomas C., Ashish K. Jha, Atul A. Gawande, Robert S. Huckman, Nicholas Bloom, and Raffaella Sadun. "Hospital Board and Management Practices Are Strongly Related to Hospital Performance on Clinical Quality Metrics." Health Affairs 34, no. 8 (August 2015): 1304–1311.
- 2010
- Article
Estimating the Attributable Cost of Physician Burnout in the United States
By: Shasha Han, Tait D. Shanafelt, Christine A. Sinsky, Karim M. Awad, Liselotte N. Dyrbye, Lynne C. Fiscus, Mickey Trockel and Joel Goh
Background: Although physician burnout is associated with negative clinical and organizational outcomes, its economic costs are poorly understood. As a result, leaders in health care cannot properly assess the financial benefits of initiatives to remediate... View Details
Keywords: Physicians; Burnout; Health; Health Care and Treatment; Employees; Cost; Programs; Policy; Health Industry
Han, Shasha, Tait D. Shanafelt, Christine A. Sinsky, Karim M. Awad, Liselotte N. Dyrbye, Lynne C. Fiscus, Mickey Trockel, and Joel Goh. "Estimating the Attributable Cost of Physician Burnout in the United States." Annals of Internal Medicine 170, no. 11 (June 4, 2019): 784–790.
- December 2007 (Revised January 2008)
- Case
Transforming Arizona's Health Care System: Developing and Implementing the Health-e Connection Roadmap
By: Lynda M. Applegate, Ajay Vinze, T.S. Raghu and Minu Ipe
Addresses the issues of leadership and change management in the process of transforming an industry through an innovative public-private partnership approach to policy making. In 2005, the Governor of Arizona issued an Executive Order to create a roadmap for the state... View Details
Keywords: Change Management; Transformation; Private Sector; Public Sector; Health Care and Treatment; Service Delivery; Partners and Partnerships; Information Technology; Health Industry; Service Industry
Applegate, Lynda M., Ajay Vinze, T.S. Raghu, and Minu Ipe. "Transforming Arizona's Health Care System: Developing and Implementing the Health-e Connection Roadmap." Harvard Business School Case 808-072, December 2007. (Revised January 2008.)
- Article
Biosimilars and Follow-On Products in the United States: Adoption, Prices, and Users
By: Ariel Dora Stern, Jacqueline L. Chen, Melissa Ouellet, Mark R. Trusheim, Zeid El-Kilani, Amber Jessup and Ernst R. Berndt
Biologic drugs account for a disproportionate share of the increase in pharmaceutical spending in the U.S. and worldwide. Against this backdrop, many look to the expanding market for biosimilars—follow-on products to biologic drugs—as a vehicle for controlling... View Details
Keywords: Pharmaceuticals; Drug Spending; Drug Pricing; Health Care and Treatment; Spending; Price; Markets; Cost Management; United States
Stern, Ariel Dora, Jacqueline L. Chen, Melissa Ouellet, Mark R. Trusheim, Zeid El-Kilani, Amber Jessup, and Ernst R. Berndt. "Biosimilars and Follow-On Products in the United States: Adoption, Prices, and Users." Health Affairs 40, no. 6 (June 2021): 989–999.